Cellectis, CiRA Partner on Induced Pluripotent Stem Cell Technology Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French genome engineering firm Cellectis and the Center for iPS Cells Research and Application of Kyoto University today announced a collaboration to combine their technologies to develop induced pluripotent stem cells, or iPS, as cellular tools.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.